Abstract
In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;